544 DELTA-1: A global, multicenter phase 2 study of ITIL-168, an unrestricted autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in adult patients with advanced cutaneous melanoma
oleh: Omid Hamid, Robert Hawkins, Paul Robbins, Gregory Daniels, Geoffrey Gibney, Amod Sarnaik, Brian Gastman, Bartosz Chmielowski, Evidio Domingo-Musibay, Sajeve Thomas, Pippa Corrie, Donald Lawrence, Yizhou Jiang, Rubén Alvarez-Rodríguez, Audrey Kennedy, Jeff Aycock, John Le Gall, Zachary Roberts
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.